Replimune Group Inc (NASDAQ:REPL)’s traded shares stood at 0.6 million during the last session, with the company’s beta value hitting 1.29. At the close of trading, the stock’s price was $13.94, to imply a decrease of -0.85% or -$0.12 in intraday trading. The REPL share’s 52-week high remains $17.00, putting it -21.95% down since that peak but still an impressive 64.71% since price per share fell to its 52-week low of $4.92. The company has a valuation of $1.05B, with an average of 0.65 million shares in intraday trading volume over the past 10 days and average of 904.94K shares over the past 3 months.
Analysts have given a consensus recommendation of Buy for Replimune Group Inc (REPL), translating to a mean rating of 1.12. Of 5 analyst(s) looking at the stock, 0 analyst(s) give REPL a Sell rating. 0 of those analysts rate the stock as Overweight while 0 advise Hold as 5 recommend it as a Buy. 0 analyst(s) have given it an Underweight rating. Estimates put the company’s current-quarter earnings per share at -0.72.
Replimune Group Inc (NASDAQ:REPL) trade information
After registering a -0.85% downside in the last session, Replimune Group Inc (REPL) has traded red over the past five days. The 5-day price performance for the stock is -0.29%, and 24.46% over 30 days. With these gigs, the year-to-date price performance is 15.11%. Short interest in Replimune Group Inc (NASDAQ:REPL) saw shorts transact 7.26 million shares and set a 8.98 days time to cover.
The extremes give us $19 and $27 for target low and target high price respectively. As such, REPL has been trading -93.69% off suggested target high and -36.3% from its likely low.
An assessment of the company’s 5-year growth patterns shows that annual earnings shrunk an estimated -19.52% for the past 5-year period. While 2025 is set for a 15.48% return in earnings, projections for the next 5 years are at 13.46% annually.
REPL Dividends
Replimune Group Inc has its next earnings report out in March. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Replimune Group Inc (NASDAQ:REPL)’s Major holders
Replimune Group Inc insiders hold 4.18% of total outstanding shares, with institutional holders owning 92.82% of the shares at 96.88% float percentage. In total, 92.82% institutions holds shares in the company, led by BAKER BROS. ADVISORS LP. As of 2024-06-30, the company held over 10.05 million shares (or 15.0899% of shares), all amounting to roughly $90.41 million.
The next major institution holding the largest number of shares is PRICE T ROWE ASSOCIATES INC /MD/ with 9.24 million shares, or about 13.8742% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $83.13 million.
We also have Price (T.Rowe) New Horizons Fund and Vanguard Total Stock Market Index Fund as the top two Mutual Funds with the largest holdings of the Replimune Group Inc (REPL) shares. Going by data provided on Sep 30, 2024 , Price (T.Rowe) New Horizons Fund holds roughly 4.39 shares. This is just over 6.42% of the total shares, with a market valuation of $61.24 million. Data from the same date shows that the other fund manager holds a little less at 2.02, or 2.96% of the shares, all valued at about 28.21 million.
